Infection Protection and Control Annual Report 2017/2018 Authors: Emma Dowling DDIPC/Head Nurse Laura Search Office Manager

Size: px
Start display at page:

Download "Infection Protection and Control Annual Report 2017/2018 Authors: Emma Dowling DDIPC/Head Nurse Laura Search Office Manager"

Transcription

1 Infection Protection and Control Annual Report 2017/2018 Authors: Emma Dowling DDIPC/Head Nurse Laura Search Office Manager P a g e 1 - Infection Prevention and Control Department

2 Compliance Criteria One... 5 Risk assessment... 5 Director of Infection Prevention & Control (DIPC) and Deputy DDIPC... 5 The Infection Control Committee... 5 Assurance Framework... 5 Infection Prevention & Control Programme... 6 Infection Prevention & Control Infrastructure... 6 Compliance Criteria Two... 7 Cleaning Services... 7 Compliance Criteria Three... 8 Compliance Criteria Four Compliance Criteria Five Surgical Site Infection Surveillance Compliance Criteria Six Compliance Criteria Seven Compliance Criteria Eight Laboratory Support Compliance Criteria Nine Policies Hand Hygiene Audit High Impact Interventions Audits Compliance Criteria Ten Link Nurse Meetings Performance against National Targets MSSA Bacteraemia Clostridium difficile Other Resistant Bacteria: Surveillance of Glycopeptide Resistant Enterococci (GRE) Bacteraemia Appendix 1 Work plan 2017/ Appendix 2 Governance structure Appendix 3 Antimicrobial Stewardship Appendix 4 VRE leaflet Appendix 5 Ward graphs Appendix 6 Infection Prevention and Control hospital webpage Appendix 7 Mandatory Training compliance Appendix 8 Published policies /SOP s Appendix 9 Hand Hygiene compliance Appendix 10 - MRSA Bacteraemia graph Appendix 11 MSSA Bacteraemia graph Appendix 12 Clostridium difficile graph Appendix 13 Escherichia coli graph P a g e 2 - Infection Prevention and Control Department

3 GLOSSARY AMR Anti-Microbial Resistance ARHAI Advisory committee on Antimicrobial Resistance and Healthcare Associated Infection BICSc The British Institute of Cleaning Science C. difficile Clostridium difficile CCG Clinical Commissioning Group CDI C. difficile infection CGC Clinical Governance Committee CNS Clinical Nurse Specialist CPA Clinical Pathology Accreditation CQC Care Quality Commission CQRG Clinical Quality review Group CQUIN Commissioning for Quality and Innovation DDIPC Deputy Director of Infection, Prevention & Control DIPC Director of Infection, Prevention & Control DoH Department of Health EoE East of England EPS Electron Prescribing System GDH Glutamate Dehydrogenase GRE Glycopeptide resistant Enterococci HCAI Healthcare Associated Infection HCPC Health and Care Professions Council HII s High Impact Interventions IOSH Institute Of Occupational Safety Health IPC Infection Prevention & Control IPCC Infection Prevention and Control Committee IPCN Infection Prevention & Control Nurse IPCT Infection Prevention & Control Team JCT Joint Commissioning Team KPI Key Performance Indicator MRSA Meticillin resistant Staphylococcus aureus MSSA Meticillin sensitive Staphylococcus aureus NHSI National Health Service Improvement NHSLA National Health Service Litigation Authority NICE National Institute for Health and Care Excellence OPD Out patients Department PALS Patient Advice and Liaison Services PHE Public Health England PIR Post Infection Review PLACE Patient Led Assessments of the Care Environment PPM Planned Programme of Maintenance QA Quality Assurance QAC Quality Assurance Committee RCA Root cause analysis SSD Sterile Services Department SSI Surgical Site Infection SLT Senior Leadership Team SUHFT Southend University Hospital Foundation Trust TKR Total Knee Replacement TMV Thermostatic mixing valve UKAS United Kingdom Accreditation Service UTI Urinary Tract Infection WTE Whole time equivalent P a g e 3 - Infection Prevention and Control Department

4 Executive Summary This report has been written by the Deputy Director of Infection Prevention and Control (DDIPC), on behalf of the Director of Infection Prevention and Control (DIPC), to summarise the work undertaken within the organisation for the period 1 st April st March As in previous years the report follows the format of the Code of Practice 10 criteria for infection prevention control (Health and Social Care Act 2008 (revised 2015) to demonstrate the Trust s compliance with the requirements of the Act. In August 2017 NHSI were invited to the Trust to assist in an external review of infection prevention processes at the Trust. The inspection RAG rated was red due to Estates issues and Governance reporting. Through a robust action plan and with engagement throughout the Trust following a re-inspection in January 2017 this rating was deescalated to Amber. Feedback from the last inspection demonstrated that there had been a notable improvement although areas for further improvement were required. A re-visit is planned for May There were 33 cases of Clostridium difficile infection at SUHFT during this period against the Department of Health objective ceiling of 30 cases. None of the cases, using the Public Health England (PHE) criteria, were classified as direct lapses in care. There were 5 cases of MRSA bacteraemia against the Department of Health zero tolerance requirements. Of the 5 cases 2 identified that policy/protocol was not followed. All lessons learnt were shared locally. Cases of Norovirus were promptly identified and managed effectively which supported minimal disruption to services and patient flow. Of the five outbreaks experienced this year only two resulted in full ward closures and two in a bay closure only. An outbreak of Norwegian (Crusted Scabies) was reported on one of the Medicine for the Elderly Wards. The Index case was admitted from Residential Care provisionally diagnosed with eczema. Following discharge back to Residential Care this was confirmed as Scabies. 10 Trust staff members were subsequently affected. In conjunction the OH, PHE and the IPCT the outbreak was managed, staff treated and contact tracing undertaken. The surveillance of surgical site infection (SSI) has been maintained during 2017/18, with lower rates of infection than national benchmarking The mean hand hygiene compliance score was 90.5%. The IPCT also carried out ad-hoc hand hygiene audits. Good antibiotic stewardship is one of the key issues in helping reduce the vulnerability of patients to developing Clostridium difficile infection. The pharmacy department have developed and implemented strategies to enhance compliance with the principles of good antibiotic stewardship. Antibiotic audits are performed on a planned schedule and monitor good prescribing practice with regard to start, stop or review dates and a written indication of the need for the antibiotic. Enhanced monitoring to control legionella and pseudomonas aeruginosa in tap water in high risk areas throughout the Trust continued. The Trust has maintained a safe water system. No hospital acquired cases of legionella have ever been linked to SUHFT buildings A continued close working relationship has been maintained with the Estates and Facilities and the Project Team has been maintained to support fit for purpose design in relation to infection prevention and control both in the development stage and during works. There have been a number of successfully completed projects, including provision of additional winter beds to support increased clinical activity, development of a new High Dependency Unit, completion of a primary care GP unit and the development of the Elective Admissions Lounge, and Diabetic Centre. Introduction Infection prevention and control remains a high priority for Southend Hospital University NHS Trust. Keeping patients safe from avoidable harm is everyone s responsibility. The Trust has a wide ranging programme of activity that focusses on continual improvement in order to deliver the best care. This report provides details of the progress made with infection prevention and control from April March It has been a challenging year with national objectives for Methicillin Resistant Staphylococcus aureus (MRSA) blood P a g e 4 - Infection Prevention and Control Department

5 stream infection and C. difficile infection, setting out a zero tolerance to avoidable infections. The DIPC reports monthly to the Trust Board of Directors for assurance purposes. This annual Report is part of the process that tracks and monitors the Trusts performance against regulatory requirements set out in the Code of Practice (Health and Social care Act, 2008). The IPCT work plans focus on implementing systems that embed IPC into the everyday practice of all Trust staff. The Infection Prevention and Control team works closely with external agencies. A strong working relationship is maintained with the local Clinical Commissioning Groups (CCG), Public Health England (PHE) and NHS Improvement (NHSi) Compliance Criteria One Systems to manage and monitor the prevention and control of infection. These systems use risk assessments and consider how susceptible service users are and any risks that their environment and other users may pose to them. The Trust Board recognises its responsibilities for overseeing infection prevention and control arrangements across the Trust guided by Compliance Criterion One. This includes the Infection Prevention and Control Strategy which outlines individual and the Trust s collective responsibility for keeping to a minimum the risks of infection and the general means by which it will prevent and control such risks. Risk assessment Infection prevention and control (IPC) is included in all Executive objectives and individual Directors are identified as responsible for the implementation of specific areas of the IPC strategy Infection Prevention and Control performance data is continually monitored and reported monthly. The Trust Board receives a report on the Infection Prevention and Control performance data at each bi-monthly trust board meeting; and quarterly reports updating on compliance with the Health and Social Care Act in addition to this an Infection Prevention and Control Annual Report is produced Compliance with the Health and Social Care Act (2008) and any action plans pertaining to infection prevention and control are monitored through the Infection Prevention and Control Committee (IPCC), Clinical Governance Committee (CGC) and the Trust Board IPC performance is discussed at meetings with the Director of Nursing and monitored through the CQRG (Clinical Quality review Group) The Infection Prevention and Control Team (IPCT) are actively involved in necessary risk assessments to ensure risks involving infection prevention are identified and managed. Issues requiring risk assessment and subsequent entry on the Trust Risk Register are monitored according to the risk score. Risks identified as 15 and above are automatically placed on the Corporate Risk Register and reviewed monthly with close scrutiny by the Director of Nursing, DIPC and the Executive and Trust Corporate Management Team. Director of Infection Prevention & Control (DIPC) and Deputy DDIPC The Director of Nursing is also the Director of Infection Prevention and Control DIPC The DIPC s job description and objectives reflect the responsibilities set out in Winning Ways: working together to reduce Healthcare Associated Infections in England (DoH 2003) The Head Nurse for Infection Prevention Control is the Deputy Director Infection Prevention and Control (DDIPC) The DDIPC and Office Manager provide a performance report to the DIPC on a monthly basis Progress on the Infection Prevention and Control Annual Work Plan (Appendix 1) will be reported by the DDIPC at the IPCC The Infection Control Committee IPCC is a key forum for the development and performance management of the infection prevention and control agenda across the organisation. The Committee meets on a monthly basis and is chaired by the DIPC with key representation from directorates across the organisation. Membership includes the IPCT, senior management and senior nurses, the Occupational Health Department, clinical governance staff, Pharmacy, Estates and Facilities staff and external bodies such as the local Public Health England Team and the Clinical Commissioning Group (CCG) Infection Prevention and Control team. Assurance Framework The Infection Prevention and Control Strategy (IC016) was reviewed in January 2017 to ensure that relevant updates in relation to regulatory requirements are added. The Strategy sets out clear objectives for the trust to ensure that patients safety in respect of IPC is delivered. The DDIPC provides a monthly performance report to the Executive Team on a number of infection prevention and control measures. This includes the Trust s current position against Department of Health ceilings for MRSA bacteraemia and C. difficile infections. The Trust Board receives a report on P a g e 5 - Infection Prevention and Control Department

6 the incidence of MRSA bacteraemia, C. difficile infection, and of learning and practice changes instigated as a result of the outcome of root cause analyses and Post Infection Reviews (PIR). Post Infection Reviews and Root Cause Analysis are undertaken for all cases of C. difficile infection and MRSA bacteraemia that are hospital apportioned. Any case not hospital apportioned is investigated by the CCG to identify any links to the hospital or community issues. The assurance process includes both internal and external measures. Internally the accountability is exercised via the IPCC ensuring that there is robust scrutiny of compliance with national standards, local policies, and clinical practice and following post infection reviews (PIR). External assurance is obtained through the Care Quality Commission (CQC) registration and unannounced visits, assessment by the National Health Service Litigation Authority (NHSLA) against their standards for infection prevention and control and the Patient Led Assessments of the Care Environment (PLACE). PLACE involves local people (known as Patient Assessors) going into hospitals as part of teams to assess how the environment supports the provision of clinical care, assessing areas such as privacy and dignity, food, cleanliness, general building maintenance and dementia. From 2016 the assessment will also look as aspects of the environment in relation to those with disabilities. It should be noted however that the assessment focuses exclusively on the environment in which care is delivered and does not cover clinical care provision or how well staff are doing their job. PLACE results were to be made public in August 2017 by the Department of Health. Infection Prevention & Control Programme The infection prevention and control programme is published annually and areas of the audit programme are monitored through the IPCC The annual work programme for 2017/2018 is attached (Appendix 1) includes details of audit and policy revision Infection Prevention & Control Infrastructure The Infection Prevention and Control Team structure is as follows: The Director of Nursing is the Director of Infection Prevention and Control WTE Head Nurse Infection Control /Deputy Director Infection Prevention and Control Band 8b WTE infection control nurses (ICN) x 2 Band 7.Since July 2017 team capacity has been significantly reduced with one Band 7 nurse vacancy WTE Infection Control Office Manager Band 6 The budget for Infection Control is held by the Director of Nursing and managed by the Head Nurse for Infection Control/DDIPC Two locum Consultant Microbiologists covering the service (see criterion 8). The Consultant Microbiologists provide an out of hour s service. (Appendix 2 Governance Structure) Movements of Patients The movement of patients is one of the most significant aspects of infection prevention and control management particularly in an outbreak situation. A key daily activity is ensuring patient safety when allocating beds or relocating patients. The IPCT produce and disseminate to relevant personnel the Daily Isolated Patient List. This document comprises of patients that are currently either: Positive MRSA carriage/previously known MRSA carriage C. difficile infection Previous C. difficile infection C. difficile carrier Multi drug resistant organisms Pulmonary Tuberculosis Norovirus Any other infection that may require isolation or IPCT input The team also advises regarding prioritisation of patients for isolation/single rooms. The IPCT ensure that all patients requiring isolation are appropriately placed and prioritise isolation requirements through risk assessment and the best use of resources available. The IPCT works closely with site managers to ensure patients safety regard to priority for isolation P a g e 6 - Infection Prevention and Control Department

7 Compliance Criteria Two Provide and maintain a clean and appropriate environment which facilitates the prevention and control of HCAI. Cleaning Services The Domestic Service department continues to meet the NHS National Specification of Cleanliness 2007 Standards. Each ward is allocated between 9-11 hours for daily operational cleaning duties with two shift patterns to provide continuous cleaning on the wards. This is reduced to 7.5 on each ward area over weekend and bank holiday periods. To help maintain these standards the department maintains cleaning equipment such as (Scrubber Dryers, ride on scrubber, Steamers/ buffers and Vacuum cleaners) for wards/ departments and public areas. The department has also recently purchased new Flood machines and cordless hand buffers. Domestic Management continues to collaborate with the Facilities training department to facilitate the transition of the Facilities Training department into a Training Centre of Excellence. This process is to enhance the current BICS standards into an in-depth NHS Cleaning module, tailored to the NHS cleaning environments and its challenges. Domestic Management continues to collaboratively work with other services such as the waste department to ensure that the waste the Trust is generating is not only disposed of correctly and safely, but to ensure there are efficient and effective methods in place that work towards reducing the Trust s carbon footprint, i.e. Tiger bag implementation, recycling of household waste etc. The Domestic services have implemented a Domestic Helpdesk, whereby all cleaning requests throughout the trust can be directed to and dealt with swiftly. Monitoring arrangements Unannounced audits are continually carried out by the Quality Assurance department throughout the Trust. Where an audited areas fails the expected pass mark, a senior manager /DDIPC will be invited to attend the re audit. Audit results are reviewed at the IPCC and reported to the Trust Board. The score rating for the risk categories as per NHS 2007 Specification of Cleanliness is as follows: Very high risk area 98 % High 95 % Significant 85 % Low 75 % Domestics Services Cleaning Patient Survey continue to be carried out to obtain patient feedback on the cleanliness of their environments. Domestic management analyse the data and continually evolve the service around the specific needs of each area. Ward Manager/Matron Logs - Are carried out by domestic supervisors weekly to ascertain the views of the senior ward management in highlighting and rectifying issues as they happen and to obtain feedback on their wards/ areas cleanliness. Supervisor Checks Are conducted daily by the domestic management team on wards to monitor that cleaning standards are being achieved on wards/departments. Domestic cleaning Technical Audits - Are conducted on a daily basis on all ward areas by domestic supervisors to help maintain the cleanliness of the areas, this information is then used to identify any attention to detail cleaning needed and a general view of the standard of each individual area. Domestic Team Briefs/ newsletters Domestic services supervisors holds monthly Domestic staff team briefs. This enables effective dissemination of information to all staff members including topics such as product changes/ implementation, training of new processes. This also is a good forum for feedback to the staff about any relevant topics regarding the cleaning service. Domestic management also provide the domestic staff with a monthly newsletter highlighting the feedback from patient surveys, audit scores and other relevant information to ensure an efficient service is provided at all times. ISO Triple Crown Accreditation The Estates and Facilities Directorate has been accredited with ISO:9001Quality management systems OHAS:18001Health and Safety and ISO: Environmental Awareness certification, which incorporates the Domestic/Cleaning department. By being accredited in these fields it evidences that the EFM/domestic service is being managed efficiently and to very high standards. These standards are audited throughout the year by a third party to ensure adequate compliance to these standards. The Domestic department P a g e 7 - Infection Prevention and Control Department

8 have a highly trained Cleaning Response Team (CRT) in place who are responsible for the following duties: Terminal and C. difficile daily cleaning Terminal cleans are requested by ward areas the CRT carry out this enhanced cleaning of the room once vacated, when needed these areas are decontaminated using Hydrogen Peroxide Vapour (HPV) decontamination equipment (Nocospray). Isolation rooms used for the care of patients with C. difficile infection have daily cleans carried out as per the daily isolated patient list, once a patient has been discharged, then a terminal clean is carried out and decontamination of the room completed using HPV technology. Also following any refurbishment or building works the CRT will carry out a deep clean of that area prior to it being handed back to the service. Detailing programme - The Domestic department has a detailing programme in place for all ward areas. Supervisors identify areas in need of attention to detail on wards and these are then carried out by the CRT/ domestic staff. Flood / spillage control Emergency response of water suction is provided when needed for any spillages/ floods within the Trust by Cleaning Response Team and deep cleaning of affected areas after incidents is then carried out. Ad Hoc Deep cleaning The domestic department receives daily requests for deep cleaning, including cleans required from post building works, major spillages etc. All of these requests are coordinated via the Domestic department s helpdesk and carried out by the Cleaning Response Team. Curtain hanging There is a 6 monthly disposable curtain changing periodical in place delivered by an external contactor (Berensden), on all ward /patient areas, however the Cleaning Response Team hang/replace any ad hoc curtain changes in between this periodical as and when these are requested by wards or in the event of an outbreak. Compliance Criteria Three Ensure appropriate anticrobial use to optimise patient outcomes and to reduce the risk of adverse events and antimicrobial resistance. Summary of Antimicrobial Stewardship Antimicrobial stewardship (AMS) is an essential element in the Trust. This is recommended in the UK five year antimicrobial resistance strategy to tackle the growing challenges of antimicrobial resistance, and optimise patients outcomes through regular ward rounds, teaching sessions and provision of electronic prescribing system and Micro Guide APP to aid prudent prescribing of antibiotics. Antimicrobial Audit Antimicrobial audits are carried out twice yearly to monitor the quality of prescribing in line with Start Smart, then Focus, principle of antimicrobial prescribing. Prompt action plans are provided where the quality is below expectation. The outcomes of the last audit carried out in March 2018 are shown below: STANDARDS % adherence achieved % of prescriptions for antimicrobial comply with the Trust guidelines 74% % of prescriptions for antimicrobial therapy that meet the inclusion criteria have 67% stop/review dates documented on e- Prescribing % of prescriptions for antimicrobial therapy that meet the inclusion criteria have 93% indication documented % of prescriptions for antimicrobial therapy that meet the inclusion criteria have drug 97% allergies documented on e-prescribing % of prescriptions appropriate for IV to ORAL switch within 48-72hrs are switched 41.7% % of prescriptions for antimicrobial therapy that meet the inclusion criteria have an appropriate antimicrobial prescribing decision documented 100% Following the audit outcomes, IV to ORAL switch bulletin was developed and placed in conspicuous areas on the wards. This is to guide prompt IV to ORAL switch by the doctors. Nurses involvement to prompt the doctors to switch is currently being considered. Pharmacy is also looking at other areas to support improvement in the quality of antimicrobial prescribing, such as mandatory e-learning. P a g e 8 - Infection Prevention and Control Department

9 Antimicrobial Consumption Antimicrobial consumption is monitored in line with the directives of Antimicrobial Resistance (AMR) CQUIN. Given that high consumption of antimicrobials is associated with increase in antimicrobial resistance; consumption data and evidence of antimicrobial prescription review are submitted to the Public Health England (PHE) at every quarter. PHE results indicate antimicrobial consumption is on the increase both nationally and within the Trust. This is attributed mainly to the use of multiple narrow spectrum antibiotics in order to reduce the use of pip-tazobactam and meropenem. Secondly, due to the increase in the level of resistance, many patients do not respond to first line treatment, hence most of these patients would require escalation of treatment with other broad spectrum antibiotics, thereby increasing the volume of antibiotics usage in the Trust. However, the report from PHE continues to indicate a low usage of antibiotics in the Trust in comparison to the mean consumption in all Trusts in England. Similarly, consumption of the two most broad spectrum antibiotics used in the country, meropenem and pip-tazobactam are lower at Southend than England average values. (See Appendix 3 for antibiotic consumption and review graphs) AMR CQUIN also requires documented evidence of inpatient antimicrobial prescription review within 72hours of starting. The minimum expected target for prescription review is 25% of all prescriptions in the first quarter, followed by 25% increment for each subsequent quarter. The Trust outcome was a starting point at 84.7%, and the percentage has remained within 90 % range since then. Antimicrobial Supply Problems As with other NHS Trusts, the Trust continues to experience intermittent supply problems with many of the essential intravenous antimicrobials. This has necessitated taking a number of steps to reduce the impact of the supply constraint; one of which includes changing the empirical recommendations for many of the common indications. The prescribers are promptly updated of any supply issue, and the available alternatives so as to optimize patients outcomes Antimicrobial Management of Uncomplicated UTI In order to reduce the nationwide rise in Gram negative bloodstream infections, which are thought to be associated with inappropriate treatment of UTI, PHE reviewed, and updated the antimicrobial treatment of uncomplicated UTI. The Trust guidelines were also updated to reflect PHE recommendations. Nitrofurantoin is now used as first line antimicrobial for UTI in the Trust, with several other options for those whom nitrofurantoin is not suitable. Empirical Antimicrobial Guidelines The guidelines are reviewed and updated yearly in collaboration with the microbiologists and infection diseases physician. National guidelines, NICE recommendations and local sensitivity patterns are always taking into consideration during this process. P a g e 9 - Infection Prevention and Control Department

10 Compliance Criteria Four Provide suitable accurate information on infections to any person concerned with providing further support or nursing/medical care in a timely fashion. Patient Advice and Liaison Services (PALS) The Trust is committed to working in partnership with patients and staff to help improve patient experience. The PALS Department is part of this commitment to provide high standards of care to support patients, carers and the public who use the Trust services. During 2017/2018 there were a number of concerns raised to the IPCT. Some of the issues included; patients acquiring an infection, environmental cleanliness and lack of communication with the family regarding the patient s infection status. These issues are addressed in the everyday work of the IPCT, for example when an IPCN visits the wards providing education on infections and communicating this information with the patients and their family/carers. This can be carried out both verbally or by providing information leaflets. Reporting Acquisitions of infections and periods of increased incidents of infections are reported through Datix and reviewed through a Post Infection Review. Patient Information Leaflets All information developed for patients or their visitors is agreed through the IPCC and undergoes patient/ user group review before publication. Leaflets giving information and advice about specific infections are reviewed and up dated on a regular basis.this year several new patient information leaflets have been written (Example of new Leaflet Appendix 4) Infection Control Data / Information Each ward area has information displaying individual ward or department performance HCAI s (IPC ward graphs Appendix 5) The Infection Prevention Control web page provides information and guidance for the public (IPC webpage Appendix 6) In the case of an outbreak, signs are used to inform visitors of the problem and patients relatives are kept informed by telephone if visiting is suspended Infection Prevention and Control policies are made available to all staff on the hospital s internal STAFFnet site as they are produced, reviewed and updated Compliance Criteria Five Ensure that patients who have or develop an infection are identified promptly and receive the appropriate treatment and care to reduce the risk of passing on the infection to other people. MRSA Elective Screening The rationale for screening non-emergency patients is to identify MRSA carriers, enabling application of topical decolonisation or suppression treatment either immediately prior to admission or on admission and the use of appropriate systemic antimicrobial prophylaxis at time of procedure, if this is appropriate. Any patient who meets a risk assessed criteria which puts them at greater risk of acquiring MRSA will be offered screening. The trust has continued to screen all elective patients in the following subsets: Major Orthopaedic, vascular, plastic or abdominal hysterectomy This covers the surgical patients who are at greatest risk from developing a MRSA infection Screening rates are monitored monthly and the proportion of patients screened is on average 89%. Although, the Trust has not achieved the internally set target of screening 95% of patients. P a g e 10 - Infection Prevention and Control Department

11 MRSA Screening of Emergency Admissions The Trust aims to screen 100% of patients admitted as emergency admissions. On average were achieve 90% compliance. Screening identifies MRSA carriers, enabling application of topical decolonisation or suppression treatment early in the admission and will inform the use of effective systemic antimicrobial prophylaxis, if this is appropriate. Patient Alert Patients who are identified as having: Positive MRSA carriage Previously known MRSA carriage C. difficile infection C. difficile carrier (GDH) Any other Multi drug resistant organism The IPCT continue add an Alert onto the Medway electronic patient record system to ensure that the above patients with an Alert organism are easily identified to all staff on subsequent admissions to facilitate their appropriate care. The IPCT updated the Alert Sicker which is placed on patient medical records to ensure it was more emphasized Microbiology results are available to staff with access to the hospital s pathology (ICE) system. Policies regarding the management of patients with specific infections are available on the Trust Intranet to ensure that patients are managed appropriately to reduce the risk of transmission to other patients and/or staff. The placement of all patients identified as having, or of being suspected as having, an infection is reviewed daily by one of the Infection Prevention and Control Nurses (IPCNs). Post Infection Reviews (PIR) Root Cause Analysis (RCA s) The IPCT have continued to contribute to PIR meetings where the root cause for all Trust MRSA bacteraemia and CDIs are discussed. Members consider whether the infection occurred through lapses in care and, if this is the case, an action plan is developed by the area/ward involved. Meetings are attended by one of the Infection Prevention and Control Nurse Specialists, to ensure decisions relating to cases are escalated where necessary. Overviews of the Trust cases are raised at the Clinical Governance Committee for assurance purposes. All lessons learnt and good practice identified is shared Trust Wide. Surgical Site Infection Surveillance The aim of SSISS is to enhance the quality of patient care by encouraging participating hospitals to use data obtained from surveillance. Rates of surgical site infection (SSI) in a specific group of surgical procedures can then be compared against a mean rate for all participating hospitals. This information can be used to review and guide clinical practice. Data is collected by a member of the IPCT using a standard surveillance sheet, surveillance the inpatient period and the post discharge period until the 60 th day. This Trust has participated in SSISS for Orthopaedic procedures since its inception in Surveillance of patients following surgery is very labour intensive so with the current staffing IPCT was only able to perform two surveillance periods for this the period 2017/2018 To obtain more accurate and meaningful data surveillance for Total Knee replacements (TKR) was undertaken for a 6 month period. Total number of operations for selected period Total Knee replacements Apr-Jun 2017 Number of SSI s for selected period All SSI s for selected period (%infected) % Jul-Sep 2017 Total number of operations for selected period Number of SSI s for selected period All SSI s for selected period (%infected) % P a g e 11 - Infection Prevention and Control Department

12 Please note. There were a total of 212 Total Knee replacements undertaken during this 6 month period and 2 infections reported. The 2 orthopaedic surgeons concerned undertook a review of the patients concerned and it was concluded in both cases that despite best practice both developed post-operative wound infections post discharge from hospital within the 60 surveillance period. Compliance Criteria Six Ensure that all staff and those employed to provide care in all settings are fully involved in the process of preventing and controlling infection. All permanent and bank staff are required to attend an induction session which includes a session on Infection Prevention and Control Specific induction sessions are provided for locum medical staff Infection Prevention and Control is part of the annual mandatory training required by all permanent and bank hospital staff and monitored through the mandatory training matrix. Specific infection prevention and control e- learning has been developed and updated annually as an alternative to attending a face to face session (See Appendix 7 for compliance graph) All policies and guidelines are published on the Intranet to which all staff and permanent contractors have access Any external contractors undertaking temporary work (e.g. building or refurbishment) in the hospital are required to produce method statements and are supervised by the Estate and Facilities staff in line with the Managing Contractors Policy. They also receive an Infection Control Tool Box talk Compliance Criteria Seven Provide or secure adequate isolation facilities. Patients who cannot be isolated due to lack of side rooms are formally risk assessed to ensure that priority for the single room is given to the patient with the greatest need. On a daily basis the Infection Prevention and Control Nurses review all patients requiring isolation. The IPCT are available to provide guidance on single room prioritisation. The IPCT are involved in capacity meetings at times of high capacity in the Trust to optimise the use of isolation facilities within the hospital. There are 120 siderooms within the Trust. As per National Guidelines, confirmed or suspected smear-positive Tuberculosis cases must be nursed in a single room with ensuite facilities. However patients with Multi Drug Resistant TB must be nursed in a negative pressure room. Therefore, if a patient is identified as Multi Drug Resistant TB they must transferred to the nearest provider with facilities for a negative pressure room. Currently the Southend University Hospital s negative pressure rooms are not operational; the nearest provider is Basildon and Thurrock University Hospital. The Royal London and Addenbrooks Hospital in Cambridge also have negative pressure room facilities. During 2017/2018 we did not have any cases which required negative pressure isolation facilities. Compliance Criteria Eight Secure adequate access to laboratory support. Consultant Microbiologists are employed by the Trust and are based on the hospital site; consultants from both Basildon and Southend visit the hub regularly to maintain a clinical presence and regular monthly meetings are held. Decisions are discussed and agreed collaboratively at these meetings by consultants from both Hospitals and the biomedical management staff from Pathology First. There are regular joint venture board meetings, clinical governance board meetings and operations and contracts meetings. The Trust was able to recruit an NHS locum Consultant Microbiologist to one post at the end of February 2017, they have been assisted by a long term agency Consultant up until December 2017 since then there was support from a Locum Consultant who has previously worked as a substantive member of staff the for the Trust. The second post continued to be advertised throughout the year without success, however a new consultant microbiologist has recently been appointed and they will take up the post in mid-summer Laboratory Support The Pathology Department at Southend Hospital is provided by a joint venture private company comprised of Southend University Hospital, Basildon and Thurrock University Hospital and IPP (Integrated Pathology Partnership); the company is called Pathology First and has a monitored contract to provide a clinically led service for all disciplines of Pathology. The Microbiology laboratory is accredited by CPA and is working towards ISO standards for accreditation to UKAS which took place in Autumn 2017, however the hub laboratory will be included in the Basildon University Hospital s UKAS extension to scope surveillance visit which is due to take place late April The main laboratory services are situated off site at a central Hub laboratory and it also has a small presence in the P a g e 12 - Infection Prevention and Control Department

13 Emergency Service Laboratory (ESL) on the hospital site. Compliance Criteria Nine Have and adhere to appropriate policies, designed for the individual s care and provider organisations that will help to prevent and control infections. Policies are reviewed and updated systematically as per the review cycle and several new policies have been developed and ratified this year. Policies Appendix 8 Infection Prevention & Control Polices Hand Hygiene Audit Hand hygiene is the single most important measure for reducing transmission of HCAIs in hospital. To ensure that the profile of this vital precaution remains high, compliance with the hand hygiene policy is audited monthly, based on the World Health Organisation s five moments for hand hygiene. The performance is recorded on the Infection Prevention Dashboard and the results for the year are shown below. In the hand hygiene audit, staff audit fellow staff members on their hand hygiene technique, knowledge of the hand hygiene policy, bare below the elbow compliance and hand washing facilities The average compliance for the year 2017/2018 was 90.50%.The IPCT also carries out ad-hoc hand hygiene audits. These results are sent to the Matrons for dissemination to their teams. (Appendix 9 Hand Hygiene Compliance Graph) High Impact Interventions Audits High Impact Interventions (HII s) are based on the care bundle model and published by the Department of Health as part of the Saving Lives: reducing infection, delivering clean and safe care programme. The HII s are specifically aimed at reducing the risks of acquitting a HCAI. Currently the following seven HIIs are audited monthly and the hospital wide results are included in the Infection Prevention and Control monthly Dashboard reports. HII1 HII2 HII3 HII4 HII5 HII6 HII7 Insertion and on-going care of central venous devices. Insertion and on-going care of peripheral intravenous devices. Renal Dialysis Catheter Care Bundle Preoperative and perioperative actions to prevent surgical site infection The reduction of ventilation associated pneumonia Insertion and on-going care of urinary catheters Reducing the risk from C. difficile The HII7 (Reducing the risk from C. difficile) audit is carried out on each patient confirmed as having C. difficile associated disease and every element of the care bundle has been carried out on each case. The high level of compliance with the HIIs is reflected in the performance against national targets. For example, the Invasive device tool (IDT) audits associated with the care of peripheral lines, central lines and urinary catheters illustrates the high standard of care provided to patients with these invasive devices. This is likely to be one of the factors in reducing not only MRSA bacteraemia but also those associated with Meticillin sensitive Staphylococcus aureus (MSSA). Compliance Criteria Ten Ensure, so far as is reasonably practicable, that care workers are free of and are protected from exposure to infections that can be caught at work and that all staff are suitably educated in the prevention and control of infection associated with the provision of health and social care. In 2017/18, the Occupational Health Department continued to provide a comprehensive service and worked closely with allied colleagues including Infection Prevention Control, Public Health England, the Blood Borne Virus team and Pharmacy to ensure that staff are protected against infection. The department has been fully involved in Infection Prevention related incidents that affect staff health such as needle stick injuries and staff exposure to skin conditions including scabies. The department has also been responsible for coordinating and delivering the Influenza Immunisation programme. In addition staff are suitably educated in protecting themselves and patients from communicable diseases. Induction training is undertaken for all new staff. P a g e 13 - Infection Prevention and Control Department

14 Staff have access to Occupational Health advice and out of hours medical advice via Accident and Emergency in the event of exposure to a blood borne virus. The Trust continues towards reducing occupational exposure to blood borne viruses including the prevention of sharps injuries through compliance with the EU directive for Safer Needles and Devices. A total of 125 sharps injury incidents/bodily fluid exposure incidents were reported to Occupational Health in A review of incidents noted a high number of incidents resulting from the use of Insulin pen needles. The Trust s Diabetic Team recently completed a trial of safer insulin pen needles. The Occupational Health Department will conduct an audit on the number of incidents relating to insulin pen needles once safer insulin pen needles have been introduced and in use. Since mid-2017 the UK has experienced a shortage of Hepatitis B vaccine due to global manufacturing issues. In response to the shortage, Public Health England developed temporary recommendations on Hepatitis B vaccine use including risk-based prioritisation of vaccine, dose-sparing and deferral of boosters. Recent correspondence from Public Health England advises that vaccine supplies are now improving and more vaccine is becoming available during However supplies will remain constrained due to backlog demand from 2017 and low UK allocations from some manufacturers. Supply management and restrictions will therefore continue until further notice. Public Health England, working with manufacturers has published a phased recovery plan to support the reintroduction of the vaccine in a phased approach to maintain continuity of supply during Occupational Health continues to receive sufficient stock of Hepatitis B vaccines for use in identified high risk groups such as Exposure Prone Procedure workers (EPP) and post exposure incidents. Catch up vaccinations commenced in May 2018 and are being phased throughout This plan is heavily reliant on Pharmacy stock levels. Occupational Health worked closely with the Infection Prevention Control team and Public Health England in managing and containing an outbreak of Norwegian Scabies. The Pharmacy Department played a crucial role by facilitating the relevant treatment to staff. The season s Influenza campaign 2017/18 came to a close in March 2018.There was a significant increase in uptake. IMMFORM reporting March 2018 shows that 61.0% of frontline staff received the Flu vaccine in comparison to the Flu campaign 2016/17 whereby 52.21% frontline staff had the vaccine. The percentage of staff who had received the vaccine as of 14th March is 62.3%. Planning is underway for the next campaign 2018/19. Education Induction, Training Programmes and On-going Education A blended learning approach continues with the provision of both face to face training and e-learning for clinical staff Training compliance rates remain high despite considerable operational pressures on the organisation throughout the year Additional education is provided on a one to one basis during routine clinical visits by the Infection Prevention and Control Nurses and in response to patient specific clinical enquiries from wards and departments. TB elearning video A new TB elearning training video was produced in The purpose of the training video is to improve the knowledge and skills of practitioners when caring for patients with suspected or confirmed Tuberculosis. The training video takes around 20 minutes to complete. It is available to all grades of staff. Link Nurse Meetings P a g e 14 - Infection Prevention and Control Department

15 The IPCT continues to provide the Infection Prevention and Control Link Nurse programme. Link Nurse sessions are run quarterly and provide an education session and, usually include a guest speaker to support the nurses to maintain their enthusiasm and commitment. Numerous topics are covered and have included for example, hand hygiene, MRSA screening and outbreak management. The sessions run for approximately two hours. The aim of these sessions is to update on any new guidance / policies and to increase the flow of Infection Prevention and Control communications. Performance against National Targets Meticillin Resistant Staphylococcus aureus (MRSA) Bacteraemia Staphylococcus aureus is a bacterium commonly found colonising humans. Although most people carry this organism harmlessly, it is capable of causing a wide range of infections from minor boils to blood stream infections. MRSA is a strain of staphylococcus aureus that is resistant to flucloxacillin and other antibiotics. The Department of Health introduced mandatory surveillance and reporting of MRSA bloodstream infections in 2001 and since April 2005 NHS acute Trusts have been set annual targets for reducing MRSA blood stream infections. For the period April 2017 to March 2018, the Trust ceiling for MRSA blood stream infections was zero Acute Trust apportioned cases. The Trust did not achieve this target with 5 MRSA bloodstream infections reported. (Appendix 10 MRSA bacteraemia Graph) Actual MRSA bacteraemia number of post 48 hour cases 0 Tolerance ceiling Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar All of the MRSA bacteraemia cases underwent a thorough Post Infection Review Process (PIR). Three of the five cases were identified and agreed as unavoidable i.e. There were no breaches in policy or practice which resulted in the case occurring. The remaining two case were agreed as avoidable due to the fact there had been breaches in local policy.the following learning points were identified : Poor Invasive Device Tool documentation- resulting in a delay in removing a device Failure to cover for MRSA with empirical antibiotics when patients are previously known to be MRSA positive Failure to include the MRSA status on a referral for line insertion. Lessons learnt were shared at ward level ensuring that all clinical staff were aware both good practice and any failures to follow policy. Also all cases with the lessons learnt were an agenda item at the IPCC, HCAI Network Group, Senior Sisters meetings, Professional Nurse and Midwifery Forum and at the Heads of Nursing Meetings. Post Infection Review (PIR) of MRSA Bacteraemia Cases The Trust undertakes a PIR following all cases of MRSA bacteraemia in order to identify key issues and themes. Action plans are developed to address issues identified. The PIR is completed by the clinicians and nursing teams involved in the care of the patient, a strategic review of the PIR is undertaken by the Microbiologist, antimicrobial pharmacist, Public Health, Infection Control Nurse and the Director of Infection Prevention and Control the results of this review are then fed back to the clinical teams. The PIR is required to be uploaded onto a PHE database within 14 working days of notification of the bacteraemia. This requirement was achieved in both cases. MSSA Bacteraemia The IPCT continue to report all Meticillin Sensitive Staphylococcus aureus Bacteraemia (MSSA) cases via the MESS system on a monthly basis. It was anticipated that national trajectories would be set for individual Trusts for MSSA bacteraemias; however, to date that has not yet occurred. For each post 48 hours of admission MSSA bacteraemia case, a review is undertaken by the IPCT to identify any key themes which require actions. (Appendix 11 MSSA Bacteraemia graph) Clostridium difficile Mandatory surveillance for C. difficile in over 65 year olds has been undertaken since Since 2007 episodes of C. difficile infection in patients between the ages of 2 and 65 have also been reportable. Episodes (or cases) are reported via the Public Health England Data Capture System. An episode consists of one or more C. difficile toxin positive stools during a 28 day period. Cases that occur on or after day 4 of a hospital P a g e 15 - Infection Prevention and Control Department

16 admission (with day 1 being the day of admission) are apportioned to the acute Trust with those identified on days 1-3 of admission likely to have been community acquired and therefore not hospital apportioned. All samples for patients who tested positive for the toxin more than 72 hours of admission (post 72 hours) are sent to reference facilities for strain typing to determine whether the cases represent cross infection. Strain typing is a specialised service provided by a reference laboratory. This is an indispensable service which helps us to manage and minimise C. difficile. Strain typing is undertaken to identify possible clusters of C. difficile cases. This year no linked cases were identified. In addition, there were no predominant strains present in the trust. (Appendix 12 - Clostridium difficile Graph) The table below shows the hospitals performance during the year. The annual ceiling for C. difficile was 30 cases. The hospital reported 33; all cases were thoroughly investigated via a Root Cause analysis (RCA). Actual Clostridium difficile (Toxin positive) - number of post 72 hour cases Year total ceiling 30 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Total The Root Cause Analysis (RCA) process is completed by the relevant ward manager and clinical team for all hospital apportioned cases. The RCA is presented at the RCA meeting and reviewed by the Infection Prevention and Control Team, Clinician, Consultant Microbiologist, Antibiotic Pharmacist and CCG Infection Prevention and Control Nurse. The RCA process is required to identify direct lapses in care which may have resulted in C. difficile infection. This information is scrutinised by the Clinical Commissioning Group (CCG). Of the 33 hospital acquired C. difficile infections, this year 0 direct lapses in care contributing to infection were identified however there were lessons learned from some of the cases. Learning/actions are fed back to the ward team, RCA findings are discussed by the DDIPC at the Infection Prevention and Control Committee and Clinical Governance Committee. If there are sufficient patients within the Trust or patients requiring review a C. difficile ward round will be undertaken. This is attended by Consultant Microbiologists, Antimicrobial Pharmacist, an Infection Prevention and Control Nurse and the Gastroenterologist. This ward round provides expert review and advice, when required, on the treatment and management of the patient. The IPCT continues to provide education throughout the year on promoting the use of the Bristol Stool Chart, the importance of rapid isolation of patients with diarrhoea and actions that reduce the transmission of CDI in the clinical area. Other Resistant Bacteria: Surveillance of Glycopeptide Resistant Enterococci (GRE) Bacteraemia GRE are resistant to Glycopeptides (antibiotics such as vancomycin) and have been nationally reported since During 2017/18 the Trust reported nil cases. Escherichia coli (E coli) bacteraemia E. coli is a species of bacteria commonly found in the intestines of humans and animals. There are many different types of E. coli, and while some live in the intestine quite harmlessly, others may cause disease. There is no objective or target associated with this bacteraemia and it is not included in our performance data. However E coli bacteraemia contribute to a high number of blood stream infections and the significant effect on both the patient and burden on the health economy should not be underestimated. In total there were 280 E coli blood stream infections in 2017/18 a significant number of patients were admitted with an established bacteraemia. The Health Secretary has launched new plans to reduce infections in the NHS. He has announced government plans to halve the number of gram-negative bloodstream infections by 2020 at an infection control summit. E. coli infections which represent 65% of gram-negative infections killed more than 5,500 NHS patients last year and are set to cost the NHS 2.3 billion by There is also large variation in hospital infection rates, with the worst performers having more than 5 times the number of cases than the best performing hospitals. The DDIPC in conjunction with the CCG plan to produce an E coli Action Plan which aims provide the Board on the progress of planed actions aimed at reducing the incidence of E.coli bacteraemia across the Trust. As approximately three-quarters of E. coli BSIs occur before people are admitted to hospital, the reduction plan will require a whole health economy approach. By using the same data definitions as MRSA and MSSA attributed cases, the Trust has reported the following cases as represented in the following graph. There appears to be a strong association with of urinary catheters for genitourinary related bacteraemia.there has been a lot of work Trust wide and within primary care in relation to reducing unnecessary urinary catheterisation. This has included training and improved documentation. (Appendix 13 E coli Bacteraemia graph) P a g e 16 - Infection Prevention and Control Department

17 18.2% decrease for plus 48 hours cases, 9.9% increase for less 48 hour cases. Carbapenemase-producing Enterobacteriaceae Carbapenems (such as Meropenem) are a powerful group of broad-spectrum antibiotics which are often the last effective defence against multi-resistant bacteria. Infections with Carbapenem-resistant enterobacteria are an emerging threat. Many have been associated with patients who have received prior treatment abroad. The Trust has a policy in place for the screening and subsequent management of suspected or confirmed cases In 2017/2018 there were nil cases reported. Outbreaks In common with Other Acute Trusts, SUHFT experienced outbreaks of diarrhoea and/ or vomiting which required restrictions to the movements of patients into and out of ward areas. The IPCT closely monitor these outbreaks where they provide advice to the ward staff and also advise the Trust on the restrictions that are required to manage the outbreak situation. Ward summary of outbreaks 2017/2018 Date of onset Ward / bay closed Date closed (if applicable) No of staff No of patients No of positive staff samples No of positive patient samples No relatives with symptoms Date ward / bay opened No of bed days lost Paglesham 01/12/2017 G Hopkins / CCU 14/12/2017 Admissions blocked, ward monitored All 3 symptomatic patients isolated n/a /12/2017 n/a n/a N/A n/a Blenheim 20/12/2017 Bay 4 closed (full) 21/12/ /12/2017 n/a Shopland 21/01/2018 Ward closed 22/01/ /01/ Windsor 11/02/2018 Bay 3 and 4 closed 12/02/ /02/ Flu/Respiratory Virus inpatient cases: In January and March 2017 several large local residential homes were closed due to respiratory outbreaks. All patients admitted to the Trust were promptly isolated, had viral swabs obtained and infection control precautions were put in place. This ensured that that cross transmission of influenza did not occur. Confirmed case summary by ward. Ward P a g e 17 - Infection Prevention and Control Department Flu organism Sample date ITU Flu B 11/01/2018 Castlepoint Flu B 14/01/2018 Princess Anne Flu B 14/01/2018 Westcliff Parainfluenza 14/01/2018 Westcliff Flu B 16/01/2018 Rochford Flu A H3 17/01/2018 Princess Anne Flu B 16/01/2018 Castlepoint Flu B 17/01/2018 Windsor Flu A 23/01/2018 ITU Human metapneumovirus 28/01/2018 Gordon Hopkins Flu B 31/01/2018 Neptune Human metapneumovirus 31/01/2018 Windsor Flu B 01/02/2018 Gordon Hopkins Flu B 01/02/2018 Rochford Influenza B 14/02/2018

18 AMU RSV 16/02/2018 Windsor Flu A 20/02/2018 P Anne Flu A 21/02/2018 Windsor Flu A 27/02/2018 AMU Flu A 28/02/2018 A/E Flu A 01/03/2018 Bedwell Flu B 27/12/2018 Windsor Flu A 02/03/2018 ITU Flu A 09/03/2018 Rochford Flu A 16/03/2018 Windsor Flu A 05/04/2018 Water Safety Water Hygiene Highlighted below is an outline of some of the measures which are in place to manage water hygiene monitoring and control within Southend University Hospital NHS Foundation Trust and satellite properties under the Trust responsibility. Legionella Bacteria Legionella is a waterborne bacterium. For it to proliferate within the hot and cold water systems it needs the presence of sludge, scale, algae, rust, and organic matter, and the ideal temperature of degrees C. Current Situation Currently the Trust has a contract with a specialist contractor who carry out a number of planned preventative maintenance (ppm s) tasks and other control measures in line with the current guidance and legislation that is in place namely: HTM 0401 and the ACOP Legionnaires disease - The control of legionella bacteria in water systems (L8), and HSG274 - Legionnaires disease: Technical guidance Part 2: The control of legionella bacteria in hot and cold water systems. In addition to the PPMs carried out by the specialist contractor the Trust also carries out regular flushing of water outlets which are used less than twice a week, which increases the turnover of water and prevents the bacteria forming in stagnant water. The Trust s WSG (Water Safety Group) have an approved sampling regime that is in place to sample water systems throughout the Trust and in satellite properties under the Trusts responsibility. If an elevated count of legionella bacterium is detected from sample results various engineering controls are implemented to eliminate the issue and the risk of the bacteria reforming. This includes: removal of flexible hoses if present, increasing temperature, removing, changing or relocating thermostatic mixing valves, descaling the outlets, increasing flushing of the outlet or chlorination of the complete water system. All outlets which have returned with elevated sample results are resampled once engineering actions have been taken, and when results come back clear they are put on to the flushing register for domestics to flush daily as a precautionary measure. Pseudomonas aeruginosa Pseudomonas aeruginosa is a waterborne bacterium which was highlighted in the press in the early part of 2012 which resulted in the death of 4 babies: 1 in Londonderry and 3 in Belfast. It is a tough bacterial strain, which is able to survive in harsh environments. It is found widely in soil and stagnant water, and can infect humans and plants. It does not usually cause illness in healthy people, but is described as an "opportunistic" organism, causing serious infection when our normal defences are weakened. This means that it represents a genuine threat to the most vulnerable hospital patients, most commonly intensive care patients, those with depleted immune systems such as cancer patients, people with severe burns and premature babies in neonatal units. In 2012 an interim document was produced advising action which needs to be taken to manage Pseudomonas aeruginosa; this was superseded by the release of the HTM Part C in To determine what areas within the hospital may possibly be affected, all those which fell under augmented care P a g e 18 - Infection Prevention and Control Department

19 were included on a sampling regime in accordance with the HTM which was risk rated by the Water Assurance Committee with support from Evolution Water Services. This is reviewed on a frequent basis. Sampling began in the later part of 2012 and is an on-going process which is carried out on 6 monthly regime. Unlike legionella sampling Pseudomonas aeruginosa sampling consists of both the hot and cold water taps being sampled. Any elevated results that are identified within the ward, are investigated for any remediation works that maybe required which typically would include investigation works, descaling of outlet, servicing of TMV valves, removal of any flexible hoses and increased flushing. The Trust continues to take this responsibility very seriously and is aware of the risks inherent in a multi building site with a number of older facilities. The Trust has a Water Quality Group which meets monthly. The purpose of this committee is to monitor and provide assurance in relation to all water safely issues. Sterile Services Sterile Services Report During the last year the Sterile Service Department (SSD) management together with the DDIPC and the Trust Clinical Director made the decision to move reprocessing of flexible endoscopes from the Endoscopy unit under the SSD umbrella to improve the delivery of the service. All of the automated endoscopy re-processors (AER s) were removed from Endoscopy Unit. The SSD Department is accredited to ISO13485: Medical Devices Quality Management System. The departmental quality system was amended to reflect the changes from the updated regulations and the external notifying body was informed, and the Trust is awaiting an audit date to assess changes put in place. Key actions/achievements in Infection Prevention and Control for 2017/2018 IPC Policy Audits Actions MRSA Screening for elective and Emergency admissions target 95% compliance Continuing support and advise in relation to Facilities Estates and the Project Team Mandatory bi-annual updates for Infection Prevention & Control for all staff groups Policies updated as required New Policies and SOPS s produced in line with current legislation All IPC Leaflets reviewed as needed Surgical Site Surveillance maintained IPC Link Nurse sessions continued TB Learning video Commode cleaning poster required to ensure standardised cleaning protocol Group A streptococcus information required regarding isolation and general Management Document folder required on STAFFnet to provide access to key infection control paperwork/order codes etc. Key Points Annual rolling programme of Infection Prevention & Control audits with timely feedback to clinical teams achieved The IPCT provided on-going support to ensure compliance with the target to help improve compliance with screening Successfully worked in conjunction with the Trust Estates and Facilities Management Team to look at building work/projects/new legislation which require Infection Prevention & Control advice Continued to provide and support the Trust programme at induction and Mandatory Training sessions All IPC Policies updated as per programme New policies produced as required All IPC Leaflets updated The IPCT has continued to follow a rolling programme Continuing work to develop link nurse role to enhance Infection Prevention & Control throughout the Trust e learning TB video produced and introduced to the Trust aimed at all levels of staff Posters updated and laminated posters provided to all clinical areas Group A Streptococcus Standard Operation Procedure produced and published on the STAFFnet Infection Prevention and Control folder in place. P a g e 19 - Infection Prevention and Control Department

20 Key Objectives 2018/2019 Annual Plan With the proposed merger of Mid Essex, Southend and Basildon Hospital Trusts the aim the Infection Control Team is to align all policies and procedures access all three sites, to set up a formal process to share learning, standardise products used and have greater communication/joint working processes. The structure at the time of producing this report has yet to be agreed and formalised. During the next 12 months the IPCT aims to ensure a high quality and effective service across the whole Trust. The IPCT will adopt a zero tolerance approach to HCAI s and ensure that all staff in the Trust are aware of their responsibilities in relation to Infection Prevention and Control. The trajectories set by the DoH for MRSA (Zero) and CDI (29) for the forthcoming 12 months remain challenging. The team will continue to carry out enhanced surveillance in line with DoH guidance for the following infections: Meticillin Resistant Staphylococcus Aureus (MRSA) BSI Clostridium difficile MSSA BSI E Coli BSI Klebsiella Pseudomonas BSI Acienetobacter BSI RCA s action plans generated will be used to provide feedback to Clinical Directorates of any key themes. The responsibility will lie with Matrons to provide the IPCT with assurance regarding the implementation of actions put into place to address issues raised. There will be continued focus and emphasis on sharing lessons learnt within all Clinical Directorates and across the MSB P a g e 20 - Infection Prevention and Control Department

21 1 Appendix 1 Work plan 2017/2018 This programme follows The Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, published July The Code of Practice on the prevention and control of infections reflects the changes required to meet the H&SC Act; Regulation 12 Safe Treatment and Care and Regulation 15 Premises and Equipment. The Code sets out the criteria used by the Care Quality Commission (CQC) registration requirement on cleanliness and infection control. Infection prevention also plays a role in optimising antimicrobial use and reducing antimicrobial resistance with good antimicrobial stewardship. This is one of the key components of the Department of Health Antimicrobial Resistance Strategy 1. To comply with the Code of Practice, the key priorities of the Infection Prevention and Control Team are: To facilitate the Trust to meet national and local performance indicators for the prevention of healthcare associated infections To ensure compliance with the Saving Lives Programme and raise standards of practice To audit compliance to Trust Infection Prevention and Control Policies To continue (and improve) established programme of audit and surveillance to provide assurance that HCAI is managed effectively To continue and improve the established education programme, in particular extending the knowledge and role of the Trust IP&C link workers Progress on this work programme will be reported to the Infection Prevention and Control Committee CQC Code of Practice Compliance criteria Programme of work 2017/2018 By whom (lead) Evidence Date to be achieved 1. Systems for the prevention and control of infection. These systems use risk assessments and consider how susceptible service users are and any risks that their environment and other users pose to them. Monthly DIPC Reports to the Board IPCC and CCG Quarterly Reports to the Clinical Governance Committee Continue to raise the profile of the Infection Prevention and Control Team through the Trust Ensure Infection Prevention Team is represented in essential Trust Committees, such as the Health and Safety Present annual programme 2018/16 (including annual audit programme) and Annual Report 2015/16 to Board of Directors through the Quality Assurance Committee. Ensure report available to the public (Published on web site). Additional briefing to Board of Directors at least yearly Deputy Director of Infection Prevention & Control (DDIPC) Deputy Director of Infection Prevention & Control (DDIPC) DON / DIPC/ DDIPC DIPC / IPC / Matrons Report Feedback Minutes Minutes/Risk register/website Monthly On-going On-going August 2015 P a g e 21 - Infection Prevention and Control Department

22 Review healthcare associated infection risks identified on the Trust Assurance Framework/Risk Register regularly (monthly, quarterly and as required) and report to Board of Directors Provide HCAI statistics for performance reporting at Board of Directors and at the IPCC, including details of trends Continue to undertake root cause analysis and Post Infection Reviews for HCAI (MRSA bacteraemia, Clostridium difficile) Evidence of lessons learnt through the RCA process are shared and agreed Evidence of actions implemented produced an action plan DIPC Minutes/Risk register Monthly / Quarterly DIPC Minutes Monthly DIPC, IPCT, Ward Managers, Matrons. Completed RCA Tools/Minutes Review all outbreaks and clusters of HCAI to the Infection Control Committee DIPC,IPCT Minutes/Quarterly Report/Annual report Assess new and existing policies with regard to infection prevention and control and make recommendations for change in line with current legislation IPCT Update programme with review dates Plan and deliver a full education programme for all staff IPCT Programme/ s /attendance records Quarterly On-going On-going On-going 2. Provide and maintain a clean and appropriate environment in managed premises that facilitates the prevention and control of infections. Update and review the e-learning module for clinical/non clinical staff Develop new methods of providing education for all staff Continue to deliver and develop quarterly Link Nurse sessions. Sessions to include RCA and PIR feedback Continue education and support for ward staff to undertake hand hygiene compliance. Hand hygiene compliance to be monitored in all in-patient areas monthly. Areas of non-compliance to be discussed at IPCC High Impact Interventions Audits undertaken monthly. Provide feedback at IPCC regarding progress and recommended actions Infection prevention participation with environmental audits and report poor compliance via the IPCC Continued Infection Prevention and Control input /participation with PLACE assessments Provide expert advice to all service developments to ensure infection risks are considered and good infection prevention facilities/practices built into the development IPCT IPCT E learning Programme / presentation material / records of undertaking Programme/ presentation material/records of attendance On-going Quarterly sessions during 2015/16 IPCT Minutes On-going Matrons IPCT Matrons IPCT IPCT Infection Prevention Dashboard Audit reports minutes PLACE reports and minutes Evidence of sign off of projects On-going Bi-monthly As required As required P a g e 22 - Infection Prevention and Control Department

23 3. Ensure appropriate antimicrobial use to optimise patient outcomes and to reduce the risk of adverse events and antimicrobial resistance. 4. Provide suitable accurate information on infections to any person concerned with providing further support or nursing/ medical care in a timely fashion 5. Ensure that people who have or develop an infection are identified promptly and receive the appropriate treatment and care to reduce the risk of passing on the infection to other people. In particular, ensure that infection prevention is considered in the built environment through provision of infection prevention expertise to capital projects from concept stages to commissioning, as well as more minor refurbishment projects Collaborate with Estates Department and Health & Safety dept. regarding Legionella management. IP&C represented at Water safety management group. Report to IPCC Collaborate with Estates Department regarding risk of Pseudomonas infection from water outlets in Augmented care areas Monitor laboratory results for Pseudomonas aeruginosa in augmented care units Antimicrobial Stewardship Group Empirical use of antibiotics pocket guidelines for prescribing in adults reviewed annually Antimicrobial audits Weekly C diff rounds Antimicrobial prescriptions reviewed Annual report to IPCC and Antimicrobial Stewardship Group Review and update letters as required - GP D/N in conjunction with CCG and local GP s Ensure evidence and data required by commissioners is presented to IPCC available and also Sharing learning continues across the South Essex Area at the quarterly IPC network meetings Continue to review and update all patient Information leaflets as guidance/circumstance requires and ensure availability DDIPC/IPCT DDIPC/IPCT Anti-microbial Pharmacist Water Safety Management Group minutes/ IPCC Minutes Water Safety Management Group minutes/ IPCC Minutes Audit reports Bi-monthly Monthly reporting On-going IPCT + CCG ICN Letters As required DDIPC Minutes monthly IPCT Minutes Quarterly IPCT Information Leaflets As required Continue to participate in the Surgical Site Surveillance Schemes IPCT Programme of On-going Reports circulated to relevant surgeons and SSI data reported at IPCC categories with collection dates/reports/attend training sessions Monitor screening of emergency and elective patients data and report to Matrons, IPCC and CCG IPCT Data % Monthly Review the Infection Prevention and Control DASHBOARD IPCT/DIPC September 2018 P a g e 23 - Infection Prevention and Control Department

24 6. Ensure that all staff and those employed to provide care in all settings are fully involved in the process of preventing and controlling infection. 7. Provide or ( secures) adequate isolation facilities 8. Secure adequate access to laboratory support as appropriate. 9. Have and adhere to policies, designed for the individual s care and provider organisations, which will help to prevent and control infections. 10. Ensure, so far as is reasonably practicable, that care workers are free of and are protected from exposure to infections that can be caught at work and that all staff are suitably educated in the prevention and control of infection associated with the provision of health and social care. See criterion 1 (programme of education, audit and monitoring of practice) IPCT Training records/agenda item at IPCC Ad hoc sessions as required e.g. Physiotherapists, Phlebotomists, Domestic Team etc Provide specialist infection prevention and control advice to new build or refurbishment projects such as bathroom facilities, isolation facilities and theatre maintenance Policy for Transfer Patients Policy requires review and update to include the isolation and screening requirement s of repatriations to the Trust Collaboration with Estates with regard to capital projects /refurbishments to ensure isolation facilities are considered and included. Collaborate with IPP (Integrated Pathology Partnership) regarding Standard operating Procedures (SOPs) relevant to IP&C Revise policies as per schedule or following publication of new evidence/guidelines Monthly review IPCT Attendance records As required Project Team /IPCT DDIPC/ Clinical Site Management Team IPCT/Estates/Projects Consultant Microbiologist/Laboratory Manager DDIPC/IPCT Sign off sheets from Estates Department Ratified Policy Documentation /Sign off sheets Minutes from meetings/ s Ratified at IPCC and the Procedural Document Group As required August 2018 As required As required As required Continue with audit programme of IPC policies compliance with Policies DDIPC /IPCT Reports at IPCC On-going Provide specialist infection prevention input to Occupational Health policies as required. Support the Occupational Health Service Department in the importance of staff having influenza vaccination Liaise with Occupational Health Service regarding any vaccinations, prophylaxis or antibiotic therapy required as circumstance dictate DIPC / IPCT DIPC/ IPCT IPCT/OH Policies Vaccination data As required P a g e 24 - Infection Prevention and Control Department

25 2 Appendix 2 Governance structure Infection Prevention & Control Assurance Framework NHS England Area Team Trust Board JCT QAC Exception Reports & also DIPC report from CGC 45 Day Execs/ Business Unit/ Exception/ Escalation CGC 7 Day EMR (Early Management Report) SLT Business Units to action Governance Team IPCC Policies of Ward SI s HCA Incidents RCA Audit Closures Environment Cleaning Audit HII Audit Compliance with Training MRSA Screening SSI s Wards & Departments 3 Appendix 3 Antimicrobial Stewardship Reducing the Impact of Serious Infections CQUIN - Graphs P a g e 25 - Infection Prevention and Control Department

26 The reduction of total antimicrobial consumption remains a challenge, mainly because the Trust uses combinations of antibiotics to provide a broad spectrum antimicrobial activity, and preserve the use of Piperacillin-tazobactam and carbapenems. It is also worth noting that consumption of antimicrobials at Southend has always been relatively low in comparison to other East of England Trusts, even prior to the CQUIN. As such, it becomes a very challenging task to reduce even further with all the interventions in place especially when dealing with an aging, immunosuppressed population. P a g e 26 - Infection Prevention and Control Department

27 4 Appendix 4 VRE leaflet SOU Appendix 5 Ward graphs P a g e 27 - Infection Prevention and Control Department

28 6 Appendix 6 Infection Prevention and Control hospital webpage 7 Appendix 7 Mandatory Training compliance P a g e 28 - Infection Prevention and Control Department

29 8 Appendix 8 Published policies /SOP s No. Policy ICN Published Date CM60 Decontamination ED Nov-17 IC005 Infectious Patients in the Operating Theatre ED May-17 IC006 Plan for the control of outbreaks in Southend Hospital ED May-17 IC009 Policy for hand decontamination ED Jan-18 IC019 Isolation Policy ED Jun-17 IC035 Linen Handling Policy ED Nov-17 IC036 Microbiological Sampling of Theatres ED Sep-17 IC038 Mattress Policy ED May-17 IC039 Management of PVL-associated Staphylococcus aureus infections ED Aug-17 IC040 Infection Prevention and Control Practice in the Operating Department ED Sep-17 IC041 Toy Cleaning Policy ED Nov-17 SOP N018 SOP N030 Whooping cough ED Jun-17 igas SOP ED Oct-17 9 Appendix 9 Hand Hygiene compliance P a g e 29 - Infection Prevention and Control Department

30 10 Appendix 10 - MRSA Bacteraemia graph 11 Appendix 11 MSSA Bacteraemia graph P a g e 30 - Infection Prevention and Control Department

31 12 Appendix 12 Clostridium difficile graph 13 Appendix 13 Escherichia coli graph P a g e 31 - Infection Prevention and Control Department

Prevention and control of healthcare-associated infections

Prevention and control of healthcare-associated infections Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process

More information

INFECTION CONTROL SURVEILLANCE POLICY

INFECTION CONTROL SURVEILLANCE POLICY INFECTION CONTROL SURVEILLANCE POLICY Version: 3 Ratified by: Date ratified: July 2016 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Head of Infection

More information

Infection Prevention and Control Strategy (NHSCT/11/379)

Infection Prevention and Control Strategy (NHSCT/11/379) Infection Prevention and Control Strategy (NHSCT/11/379) September 2010 September 2010 Contents Page No. 1. Foreword 1 2. Introduction 2-3 3. Key Principles 4-5 4. Objectives 6-13 5. Organisational Arrangements

More information

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 Healthcare-associated infections: prevention ention and control Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 NICE 2017. All rights reserved. Subject to Notice of rights

More information

TRUST BOARD. Date of Meeting: 05/10/2010

TRUST BOARD. Date of Meeting: 05/10/2010 TRUST BOARD Date of Meeting: 05//20 Enclosure: 7 Agenda Item No: 8.3 Title of Report: Interim Report for Infection Prevention and Control 20-2011 Aims: To inform the Board of the work of the Trust in controlling

More information

The safety of every patient we care for is our number one priority

The safety of every patient we care for is our number one priority HUMBER NHS FOUNDATION TRUST INFECTION PREVENTION AND CONTROL STRATEGY 2015-2017 1. Introduction Healthcare associated infections (HCAI) continue to be a major cause of patient harm and although nationally

More information

Infection Prevention & Control Annual Report 2011/2012

Infection Prevention & Control Annual Report 2011/2012 Infection Prevention & Control Annual Report 2011/2012 Board of Directors Approval date: 1 November 2012 Infection Prevention & Control Committee Submission date: 1 August 2012 Position at 31 March 2012

More information

Infection Control. Annual Report 2014 / 15

Infection Control. Annual Report 2014 / 15 Infection Control Annual Report 2014 / 15 July 2015 Report 1. Introduction and Background 1.1 The Trust supports the principle that healthcare acquired infections should be prevented wherever possible

More information

Infection Prevention and Control Annual Report 2012/13

Infection Prevention and Control Annual Report 2012/13 Infection Prevention and Control Annual Report 2012/13 Infection Prevention and Control Annual Report 2012/13 1 Contents 1. Executive Overview 2. Key Achievements 3. Infection Prevention and Control Team

More information

Infection Prevention. & Control. Report

Infection Prevention. & Control. Report Infection Prevention & Control Report April 2012 March 2013 Author Joanne Raper, Infection Prevention & Control Nurse Manager Page 1 of 10 1.0 Purpose of the Paper The purpose of this report is to provide

More information

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT 2006-2007 Author(s) Gill Harris, Director of Infection Prevention and Control EXECUTIVE

More information

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Issue Action Risk to Year-end trajectory for C difficile infections is 29 cases. Week commencing 09.12.13 - Performance

More information

INFECTION PREVENTION & CONTROL ANNUAL REPORT 2016 / 2017

INFECTION PREVENTION & CONTROL ANNUAL REPORT 2016 / 2017 INFECTION PREVENTION & CONTROL ANNUAL REPORT 1 2016 / 2017 AUTHOR Mustafa Ahmed Governance Improvement Manager DIRECTOR OF INFECTION PREVENTION & CONTROL Garry Marsh Executive Director of Patient Services

More information

HEI self-assessment. Completing the self-assessment - Guidance to NHS boards

HEI self-assessment. Completing the self-assessment - Guidance to NHS boards HEI self-assessment Completing the self-assessment - Guidance to NHS boards INTRODUCTION This document should be read in conjunction Healthcare Improvement Scotland healthcare associated infection (HAI)

More information

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012 SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS C 22 FEBRUARY 2012 Subject: Supporting : Author: Status (see footnote): Update on the Clostridium difficile (C.diff)

More information

Infection Prevention and Control Annual Report Produced by: The Director of Infection Prevention and Control

Infection Prevention and Control Annual Report Produced by: The Director of Infection Prevention and Control Infection Prevention and Control Annual Report 2009 Produced by: The Director of Infection Prevention and Control Reviewing the period: January 2009 - December 2009 Approved by Infection Control Committee:

More information

Infection Prevention & Control Annual Report 2016/2017

Infection Prevention & Control Annual Report 2016/2017 Infection Prevention & Control Annual Report 2016/2017 Board of Directors Approval date: Infection Prevention & Control Committee Submission date: 04/01/18 14/12/17 Position at 31 st March 2017 WTE = whole

More information

HEALTHCARE ASSOCIATED INFECTION PREVENTION AND CONTROL REPORT JUNE 2016

HEALTHCARE ASSOCIATED INFECTION PREVENTION AND CONTROL REPORT JUNE 2016 Appendix--75 Borders NHS Board HEALTHCARE ASSOCIATED INFECTION PREVENTION AND CONTROL REPORT JUNE Aim The purpose of this paper is to update Board members of the current status of Healthcare Associated

More information

NHS Highland Infection Prevention & Control Annual Work Plan End of Year

NHS Highland Infection Prevention & Control Annual Work Plan End of Year NHS Highland Board 5 April Item 5.7 NHS Highland & Control Annual Work Plan End of Year Update for COIC Prepared by Catherine Stokoe and Jonty Mills (as of 01/03/) Objective Activity Time Scale Lead Officer

More information

REPORT SUMMARY SHEET

REPORT SUMMARY SHEET Quality care for you, with you REPORT SUMMARY SHEET Meeting: Date: Title: Lead Director: Corporate Objective: Purpose: High level context: Trust Board 27 th October 2016 Infection Prevention and Control

More information

Infection Prevention and Control Policy

Infection Prevention and Control Policy Infection Prevention and Control Policy March 2012 Ref: PCD053 (v5) Status: Infection Prevention and Control Policy Policy Reference Number IC017 Status Version 5 Implementation Date September 2007 Current/Last

More information

abc INFECTION CONTROL STRATEGY

abc INFECTION CONTROL STRATEGY abc INFECTION CONTROL STRATEGY 1. INTRODUCTION East and North Hertfordshire NHS Trust (ENHT) considers the reduction of Healthcare Associated infections (HCAI) a key component of patient safety systems

More information

Staffordshire and Stoke on Trent Partnership Trust Infection Prevention and Control team. Director of Infection Prevention and Control Annual Report

Staffordshire and Stoke on Trent Partnership Trust Infection Prevention and Control team. Director of Infection Prevention and Control Annual Report Staffordshire and Stoke on Trent Partnership Trust Infection Prevention and Control team Director of Infection Prevention and Control Annual Report April 215 to March 216 1 Executive Summary The Health

More information

Infection prevention and control

Infection prevention and control Infection prevention and control Annual Report 2016/17 National Infection Prevention and Control Strategic Management Team Dee Sissons Executive Director of Nursing, Marie Curie Director, Infection Prevention

More information

Annual Infection Prevention & Control Report Infection Prevention & Control is everyone s business

Annual Infection Prevention & Control Report Infection Prevention & Control is everyone s business Annual Infection Prevention & Control Report 2013-2014 Infection Prevention & Control is everyone s business Infection Prevention and Control Committee August 2014 Contents Page Executive Summary Surveillance

More information

Infection Prevention and Control Assurance

Infection Prevention and Control Assurance Infection Prevention and Control Assurance Who Should Read This Policy Target Audience All Clinical Staff Version 1.0 November 2015 Infection Prevention and Control Assurance Policy Ref. Contents Page

More information

THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION

THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION Compliance 1) Systems to manage and monitor the prevention and control of infection. These systems use risk assessments and consider how susceptible

More information

Infection Prevention and Control. Quarterly Report

Infection Prevention and Control. Quarterly Report Infection Prevention and Control Quarterly Report 1 st July 2009 30 th September 2009 Dr Nick Harper Director of Infection Prevention and Control Mrs Johanne Lickiss Nurse Consultant Infection Prevention

More information

Annual Report Infection Prevention and Control. RDaSH. Helen Dabbs Deputy Chief Executive/Director of Nursing & Partnerships

Annual Report Infection Prevention and Control. RDaSH. Helen Dabbs Deputy Chief Executive/Director of Nursing & Partnerships RDaSH Infection Prevention and Control Annual Report Helen Dabbs Deputy Chief Executive/Director of Nursing & Partnerships Dr Deborah Wildgoose Deputy Director of Nursing and Standards Rachel Millard Head

More information

Infection Prevention and Control Annual Report 1 st April st March 2013

Infection Prevention and Control Annual Report 1 st April st March 2013 Infection Prevention and Control Annual Report 1 st April 2012-31 st March 2013 Patient friendly version Edited by: Fighting Infection Together (FIT) group Table of Contents Section: Page: 1 Introduction

More information

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust Inspecting Informing Improving Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust December 2008 Outcome of inspection for: Hospital(s) visited: West Hertfordshire Hospitals NHS Trust

More information

Establishing an infection control accreditation programme to control infection

Establishing an infection control accreditation programme to control infection International Journal of Infection Control www.ijic.info ISSN 1996-9783 Establishing an infection control accreditation programme to control infection Julie Parker Sheffield Teaching Hospitals NHS Foundation

More information

Director of Infection Prevention and Control Annual Report 01 April March 2013

Director of Infection Prevention and Control Annual Report 01 April March 2013 Director of Infection Prevention and Control Annual Report 01 April 2012 31 March 2013 Agenda Item: Reference: Meeting Name: Board Meeting Meeting Date: 3 rd June 2013 Lead Director: Lisa Cooper Job Title:

More information

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13 Introduction purpose: West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan 2012-2013 [Updated 19/3/13] Item 37/13 This action plan has been developed by West Hertfordshire

More information

Job Title 22 February 2013

Job Title 22 February 2013 Surveillance of Infection Policy HH(1)/IC/613/13 Previous document(s) being replaced Location Policy Policy Name RHCH CP021 Surveillance Policy BNHH IC/289/09 Surveillance of Infection Protocol Document

More information

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST HEALTHCARE ASSOCIATED INFECTIONS (HCAI)

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST HEALTHCARE ASSOCIATED INFECTIONS (HCAI) THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST HEALTHCARE ASSOCIATED INFECTIONS (HCAI) Agenda item A4(i) EXECUTIVE SUMMARY The paper highlights the increasingly challenging HCAI targets for the

More information

Board of Directors Infection Prevention and Control Report. Dr Claire Thomas, DIPC

Board of Directors Infection Prevention and Control Report. Dr Claire Thomas, DIPC Board of Directors 25 November Report to: Title: Author: Sponsoring Director Purpose: Decision Sought: Board of Directors Infection Prevention and Control Report Dr Claire Thomas, DIPC Donna Green 6 monthly

More information

Infection Prevention and Control (IPC) Annual Programme 20010/11

Infection Prevention and Control (IPC) Annual Programme 20010/11 Infection Prevention and Control (IPC) Annual Programme 20010/11 1. Introduction The Code of Practice for the Prevention and Control of Healthcare Associated Infections (DH, 2009) otherwise known as the

More information

CLOSTRIDIUM DIFFICILE ACTION PLAN

CLOSTRIDIUM DIFFICILE ACTION PLAN CLOSTRIDIUM DIFFICILE ACTION PLAN Action plan to address the rise in cases of Clostridium difficile (C.diff) at Sheffield Teaching Hospitals NHS Foundation Trust ACTION KEY MILESTONES PERSON RESPONSIBLE

More information

Director of Infection Prevention and Control

Director of Infection Prevention and Control Director of Infection Prevention and Control 2016-17 2 Contents Page 1. Executive Summary 4 2. Infection prevention and control arrangements 5 3. Healthcare Associated Infection Performance 6 3.1. Mandatory

More information

Connolly Hospital Infection Prevention and Control Quality Improvement Plan 14 th March 2013

Connolly Hospital Infection Prevention and Control Quality Improvement Plan 14 th March 2013 Connolly Hospital Infection Prevention and Control Quality Improvement Plan 14 th March 2013 1. Summary The Infection Prevention and Control Quality Improvement Plan clearly defines the priorities for

More information

COMPLETION DATE 2.1 Governance Improve medical attendance at IPPC meeting records Clinical Directors Q

COMPLETION DATE 2.1 Governance Improve medical attendance at IPPC meeting records Clinical Directors Q University Hospital Waterford (UHW) Quality improvement Plan - HIQA PCHAI Unannounced Monitoring Inspection on 5.9.2017 (Report Published 4 th December 2017) QIP dated 31 st Recommendations Section 2 2.1

More information

MRSA: National developments, Progress, Challenges and Targets

MRSA: National developments, Progress, Challenges and Targets MRSA: National developments, Progress, Challenges and Targets Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London The MRSA challenge - 2007 Bacteraemia

More information

Recommendations: Board members are requested to note the content of the report and priority areas for the coming year.

Recommendations: Board members are requested to note the content of the report and priority areas for the coming year. Trust Board Date: 24/05/2017 Purpose of the Report: Item: Annual Report Infection Prevention & Control. Enclosure: The Trust Board are provided with the Annual Report of Infection Prevention & Control

More information

Annual Complaints Report 2014/15

Annual Complaints Report 2014/15 Annual Complaints Report 2014/15 1.0 Introduction This report provides information in regard to complaints and concerns received by The Rotherham NHS Foundation Trust between 01/04/2014 and 31/03/2015.

More information

The prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6)

The prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6) NATIONAL AUDIT OFFICE STUDY The prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6) National Audit Office study The prevention, management

More information

Report of the unannounced inspection at Wexford General Hospital.

Report of the unannounced inspection at Wexford General Hospital. Report of the unannounced inspection of the prevention and control of healthcare associated infection at X Hospital Report of the unannounced inspection at Wexford General Hospital. Monitoring programme

More information

REPORT SUMMARY SHEET

REPORT SUMMARY SHEET Quality care for you, with you REPORT SUMMARY SHEET Meeting: Date: Title: Lead Director: Corporate Objective: Purpose: High level context: Trust Board 29 th September 2016 Infection Prevention and Control

More information

Annual Infection Prevention and Control Report Produced by Colette Thomas Lead Nurse Infection Prevention and Control Page 1

Annual Infection Prevention and Control Report Produced by Colette Thomas Lead Nurse Infection Prevention and Control Page 1 Infection Prevention And Control Annual Report 2014-2015 Presented by: Written and Compiled by: Contributors: Executive Lead: Director of Infection Prevention and Control Lead Nurse, Infection Prevention

More information

Infection Prevention and Control Strategy

Infection Prevention and Control Strategy Infection Prevention and Control Strategy 2015 2018 Foreword This three year plan has been produced to support the work which has been taken forward in previous years across the organisation to reduce

More information

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can

More information

This paper provides detail of actions to reduce the incidence of Clostridium difficile at Airedale NHS Foundation Trust (ANHST).

This paper provides detail of actions to reduce the incidence of Clostridium difficile at Airedale NHS Foundation Trust (ANHST). Airedale NHS Foundation Trust Board of Directors: 27 February 2013 Title: Update on Actions to Reduce the Incidence of Clostridium difficile at Airedale NHS Foundation Trust Author: Allison Charlesworth,

More information

Infection Prevention Control Committee. Annual Report. April 2016 to March Working together to break the chain of infection

Infection Prevention Control Committee. Annual Report. April 2016 to March Working together to break the chain of infection Infection Prevention Control Committee Annual Report April 2016 to March 2017 Working together to break the chain of infection 1. Executive Summary Biofire Using funds released from internal cost saving

More information

Infection Prevention and Sepsis Team Annual Report

Infection Prevention and Sepsis Team Annual Report 2016/17 Infection Prevention and Sepsis Team Annual Report We will be a leading centre in healthcare driven by excellence in patient experience, research, teaching and education. Helen Bucior Infection

More information

THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION

THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION Compliance 1) Systems to manage and monitor the prevention and control of infection. These systems use risk assessments and consider how susceptible

More information

Arrangements. Version 10

Arrangements. Version 10 UNIQUE IDENTIFIER NO: C-64-2014 Nurse Section A - Arrangements Version 10 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or

More information

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can

More information

Healthcare associated infections across the health and social care community

Healthcare associated infections across the health and social care community Healthcare associated infections across the health and social care community Professor Brian Duerden CBE Inspector of Microbiology and Infection Control, Department of Health, London Infection is different..it

More information

The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England

The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England Report by the Comptroller and Auditor General The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England Ordered by the House of Commons to be printed 14 February 2000 LONDON:

More information

Trust Policy for the Prevention and Control of Infection

Trust Policy for the Prevention and Control of Infection Trust Policy for the Prevention and Control of Infection Approved by Version Issue Date Review Date Contact Person IPCC October 2015 3 October 2015 October 2018 Paul Bolton Page 1 of 25 1. Title of document/service

More information

EAST AND NORTH HERTFORDSHIRE NHS TRUST CHIEF EXECUTIVE S REPORT

EAST AND NORTH HERTFORDSHIRE NHS TRUST CHIEF EXECUTIVE S REPORT EAST AND NORTH HERTFORDSHIRE NHS TRUST CHIEF EXECUTIVE S REPORT Agenda Item No. 7 23 rd January 2008 1. Christmas Day Visit From Mayor of Stevenage and General Secretary, Royal College of Nursing Alison

More information

JOB DESCRIPTION. Deputy Director of Nursing - Tissue Viability. Director of Nursing. Tissue Viability Support Tissue Viability Nurse

JOB DESCRIPTION. Deputy Director of Nursing - Tissue Viability. Director of Nursing. Tissue Viability Support Tissue Viability Nurse JOB DESCRIPTION Job Title: Reporting to (title): Tissue Viability Nurse Specialist Deputy Director of Nursing - Tissue Viability Professionally Accountable to (title): Responsible for Supervising (if appropriate):

More information

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas This toolkit includes examples advice leaflets and forms which may be helpful for use by teams or

More information

Clostridium difficile Infection (CDI) Trigger Tool

Clostridium difficile Infection (CDI) Trigger Tool Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland March 2014 Version 3.0 A CDI trigger is the number of new CDI

More information

Infection Prevention and Control Annual Report

Infection Prevention and Control Annual Report Infection Prevention and Control Annual Report 2015-16 Infection Prevention and Control Annual Report 2015-16 CONTENTS EXECUTIVE SUMMARY... 1 1. INTRODUCTION... 3 2. INFECTION PREVENTION AND CONTROL ARRANGEMENTS...

More information

INFECTION PREVENTION & CONTROL. ANNUAL REPORT Northern Devon Healthcare NHS Trust

INFECTION PREVENTION & CONTROL. ANNUAL REPORT Northern Devon Healthcare NHS Trust INFECTION PREVENTION & CONTROL ANNUAL REPORT 2013-14 Northern Devon Healthcare NHS Trust incorporating community services in Exeter, East and Mid Devon 1 Kevin Marsh David Richards Joint Directors of Infection

More information

Laying the Foundations the first DIPC annual report for Dudley and Walsall Mental Health NHS Partnership Trust. Alison Geeson Head of Nursing

Laying the Foundations the first DIPC annual report for Dudley and Walsall Mental Health NHS Partnership Trust. Alison Geeson Head of Nursing Director of Infection Prevention and Control (DIPC) Annual Report April 2009 to March 2010 Laying the Foundations the first DIPC annual report for Dudley and Walsall Mental Health NHS Partnership Trust

More information

Infection Prevention and Control Annual Report

Infection Prevention and Control Annual Report Infection Prevention and Control Annual Report 2016/2017 Dr Deborah Wildgoose Director of Nursing and Quality Lisa Connor Associate Nurse Director Doncaster Care Group Infection Prevention and Control

More information

Item E1 - Bart s Health Quality Indicators

Item E1 - Bart s Health Quality Indicators Item E1 - Bart s Health Quality Indicators 1.0 Purpose 1.1 The purpose of this report is to provide the CCG Board with an update on quality matters across pertaining to our main local Provider organisations.

More information

Healthcare Acquired Infections

Healthcare Acquired Infections Healthcare Acquired Infections Emerging Trends in Hospital Administration 9 th & 10 th May 2014 Prof. Hannah Priya HICC In charge What is healthcare acquired infection? An infection occurring in a patient

More information

Combating Healthcare Associated Infections in the NHS. Inspector of Microbiology and Infection Control, Department of Health, London

Combating Healthcare Associated Infections in the NHS. Inspector of Microbiology and Infection Control, Department of Health, London Combating Healthcare Associated Infections in the NHS Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London 2007 -The challenge of HCAI MRSA bacteraemia

More information

Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014

Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014 Background Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014 The C.difficile objective for EKHUFT in 2013 2014 was 29 cases and in April 2013, the

More information

The challenge for today - best practice, better outcomes and safer healthcare

The challenge for today - best practice, better outcomes and safer healthcare The challenge for today - best practice, better outcomes and safer healthcare A practical guide to improving practice & monitoring compliance against the National Quality Standard for Healthcare associated

More information

Hospital Cleanliness Report March 2013

Hospital Cleanliness Report March 2013 PAPER: SFT3379 Hospital Cleanliness Report March 2013 PURPOSE: To update the Trust Board on the Cleanliness Compliance against national specifications that support the Clean Hospital Agenda MAIN ISSUES:

More information

COVENTRY AND RUGBY CLINICAL COMMISSIONING GROUP

COVENTRY AND RUGBY CLINICAL COMMISSIONING GROUP COVENTRY AND RUGBY CLINICAL COMMISSIONING GROUP Report To: Governing Body 11 September 2013 Report From: Title of Report: Purpose of the Report: Jacqueline Barnes, Executive Nurse The Nursing and Quality

More information

Title: Annual report of the infection prevention and control team April

Title: Annual report of the infection prevention and control team April Title: Annual report of the infection prevention and control team April 2016-17 Purpose: To report activity of the infection prevention and control team Document application: Trust wide Responsibilities

More information

Quality and Safety Committee. Prevention and Control of Healthcare Acquired Infections performance to February 2012

Quality and Safety Committee. Prevention and Control of Healthcare Acquired Infections performance to February 2012 Betsi Cadwaladr University Health Board Committee Paper 05.04.12 Item QS12/37.5 Name of Committee: Subject: Summary or Issues of Significance National / Local Objectives Addressed: Legislation or Healthcare

More information

Infection Prevention and Control

Infection Prevention and Control Infection Prevention and Control Annual Report 2011/12 Presented by: Director of Infection Prevention and Control Written and Compiled by: Lead Nurse, Infection Prevention and Control Contributors: Hotel

More information

Board Meeting 01/12/16 Open Session Item 10. Performance and Quality Report to the Board December 2016

Board Meeting 01/12/16 Open Session Item 10. Performance and Quality Report to the Board December 2016 Board Meeting 01/12/16 Open Session Item 10 Performance and Quality Report to the Board ember Introduction This report summarises key areas of performance which includes, but is not limited to, Local Delivery

More information

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital Open and Honest Care in your Local Hospital Report for: Royal Wolverhampton NHS Trust January 2016 The Open and Honest Care: Driving Improvement Programme aims to support organisations to become more transparent

More information

Protocol for the Prevention and Management of Clostridium difficile.

Protocol for the Prevention and Management of Clostridium difficile. Protocol for the Prevention and Management of Clostridium difficile. Policy Profile Policy Reference: Clinical care protocol 14. App D Clin 2.0 Version: Version 2.1 Author: Selma Mehdi, Lead Nurse Infection

More information

To Dip or Not To Dip

To Dip or Not To Dip To Dip or Not To Dip a patient centred approach to improve the management of UTI in the Care Home environment FIS 30 th November 2017 #ToDipOrNotToDip #FIS17 Elizabeth Beech on behalf of colleagues National

More information

Isolation Care of Patients in Isolation due to Infection or Disease

Isolation Care of Patients in Isolation due to Infection or Disease Infection Prevention and Control Assurance - Standard Operating Procedure 6 (IPC SOP 6) Isolation Care of Patients in Isolation due to Infection or Disease Why we have a procedure? The spread of infection

More information

Clostridium difficile Infection (CDI) Trigger Tool

Clostridium difficile Infection (CDI) Trigger Tool Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland V2.0 November 2011 A CDI Trigger is the point at which the Infection

More information

Foundation Trust Board of Directors 25 May Infection Prevention and Control and Pressure Ulcer Prevention Activity 2016/17

Foundation Trust Board of Directors 25 May Infection Prevention and Control and Pressure Ulcer Prevention Activity 2016/17 Foundation Trust Board of Directors 25 May 2017 Infection Prevention and Control and Pressure Ulcer Prevention Activity 2016/17 M Situation This report provides an overview of the NHFT Infection Prevention

More information

Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)

Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance

More information

HCAI Local implementation team action plan

HCAI Local implementation team action plan HCAI Local implementation team action plan Item Type Report Authors New Governance HCAI Group Publisher New Governance HCAI Group Download date 16/09/2018 18:12:09 Link to Item http://hdl.handle.net/10147/110814

More information

CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST Report of: Director of Patient Services/Chief Nurse/Director of Infection Prevention & Control Paper prepared by: Nurse Consultant Infection

More information

Director of Infection Prevention and Control (DIPC) Annual Report. April 2011 to March 2012

Director of Infection Prevention and Control (DIPC) Annual Report. April 2011 to March 2012 Director of Infection Prevention and Control (DIPC) Annual Report April 2011 to March 2012 The third DIPC annual report for Dudley and Walsall Mental Health NHS Partnership Trust AUTHORS: Alison Geeson

More information

Annual DIPC Infection Prevention Report. And. Annual Programme

Annual DIPC Infection Prevention Report. And. Annual Programme Annual DIPC Infection Prevention Report 1 st April 2015 31 st March 2016 And Annual Programme 1 st April 2016 31 st March 2017 Authors: Marie Thompson Director of Nursing and Quality, DIPC Dr Ruth Palmer,

More information

Report by Liz McClurg, Infection Control Manager on behalf of Heidi May, Board Nurse Director & Executive Lead, Infection Prevention & Control

Report by Liz McClurg, Infection Control Manager on behalf of Heidi May, Board Nurse Director & Executive Lead, Infection Prevention & Control INFECTION PREVENTION & CONTROL ANNUAL WORK PLAN (2013 2014) Highland NHS Board 4 June 2013 Item 5.5(c) Report by Liz McClurg, Infection Control Manager on behalf of Heidi May, Board Nurse Director & Executive

More information

Infection Prevention and Control Policy

Infection Prevention and Control Policy Infection Prevention and Control Policy Version: 2 V Ratified By: Quality Sub Committee R Date Ratified: vember 2016 D Date Policy Comes Into Effect: vember 2016 D Author: Karen Taylor A Responsible Director:

More information

North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2)

North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2) North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2) No. Objective Actions Lead Date of 1 Leadership throughout Accountability

More information

Pulmonary Tuberculosis Policy

Pulmonary Tuberculosis Policy Pulmonary Tuberculosis Policy Author: Owner: Publisher: Linda Horton-Fawkes Infection Prevention Team Compliance Unit Date of previous issue: August 2005 Version: 3 Date of version issue: May 2011 Approved

More information

Key prevention strategies for MRSA bacteraemia: a case study. Dr. Michael A. Borg Director of Infection Prevention & Control Mater Dei Hospital Malta

Key prevention strategies for MRSA bacteraemia: a case study. Dr. Michael A. Borg Director of Infection Prevention & Control Mater Dei Hospital Malta Key prevention strategies for MRSA bacteraemia: a case study Dr. Michael A. Borg Director of Infection Prevention & Control Mater Dei Hospital Malta 1 Mortality following Staphylococcus aureus bacteraemia

More information

For further information please contact: Health Information and Quality Authority

For further information please contact: Health Information and Quality Authority For further information please contact: Infection Prevention and Control 13-15 The Mall Beacon Court Bracken Road Sandyford Dublin 18 Phone: +353 (0)1 293 1140 Email: ipc@hiqa.ie URL www.hiqa.ie Guide

More information

Infection Prevention and Control Annual Report 2015/16

Infection Prevention and Control Annual Report 2015/16 Infection Prevention and Control Annual Report 2015/16 Amanda Hemsley, Senior Nurse Advisor for Infection Prevention and Control Report Period: April 2015 March 2016 Report Date: June 2016 Infection Prevention

More information

Quality Assurance Framework

Quality Assurance Framework Quality Assurance Framework NHS Bromley Clinical Commissioning Group Quality Assurance Framework was developed to support the commissioning, contract monitoring and procurement processes. NAME OF ORGANISATION/SERVICE

More information

SUBJECT: Healthcare Associated Infection (HCAI) Reporting Template

SUBJECT: Healthcare Associated Infection (HCAI) Reporting Template Meeting of Lanarkshire NHS Board: 31 uary 2018 Lanarkshire NHS Board Kirklands Bothwell G71 8BB Telephone: 098 855500 www.nhslanarkshire.org.uk SUBJECT: Healthcare Associated Infection (HCAI) Reporting

More information

Annual Report Infection Prevention and Control. RDaSH. Helen Dabbs Deputy Chief Executive/Director of Nursing & Partnerships

Annual Report Infection Prevention and Control. RDaSH. Helen Dabbs Deputy Chief Executive/Director of Nursing & Partnerships RDaSH Infection Prevention and Control Annual Report L-R: Karen Foltyn - Senior Clinical Nurse Specialist IPC, Rachel Millard - Head of Clinical Effectiveness, Emma Stables - Senior Clinical Nurse Specialist

More information